ArticleCureus2026
Artificial Intelligence in Febrile Neutropenia: From Risk Scores to Real-Time Clinical Decision Support.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Febrile neutropenia remains one of the most urgent and clinically challenging complications in oncology care, where timely recognition and decision-making can significantly influence outcomes. While traditional risk assessment tools have long supported clinicians in stratifying patients, they are limited in their ability to adapt to the complexity and rapidly changing nature of clinical situations. In this context, artificial intelligence (AI) is increasingly being explored as a way to complement existing approaches and support more responsive and individualized care. This editorial discusses how the role of AI in febrile neutropenia is evolving, moving from static risk scoring systems toward the possibility of real-time clinical decision support. It highlights both the potential of these tools to enhance clinical workflows and the practical challenges that still need to be addressed before widespread adoption. As these technologies continue to develop, careful integration into clinical practice may help improve how clinicians assess risk and manage patients with febrile neutropenia.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.